Clinical evidence of efficacy of red yeast rice and berberine in a large controlled study versus diet

Mediterranean Journal of Nutrition and Metabolism

Volumn 4, Issue 2, 2011, Pages 133-139

  Trimarco, Bruno ^a   Benvenuti, Claudio ^b   Rozza, Francesco ^a   Cimmino, Claudia Sara ^a   Giudice, Renata ^a   Crispo, Salvatore ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Medical Department   (Italy)

Author keywords

Berberine; Dyslipidemia; Metabolic syndrome; Nutraceuticals; Red yeast

Indexed keywords

ASTAXANTHIN; BERBERINE; FOLIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NUTRACEUTICAL; POLICOSANOL; TRIACYLGLYCEROL; UBIDECARENONE; XUEZHIKANG;

ADULT; ARTICLE; ASTHENIA; BITTER TASTE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; COMPARATIVE EFFECTIVENESS; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DIET SUPPLEMENTATION; DIZZINESS; DRUG ACTIVITY; DRUG EFFECT; DRUG SAFETY; DRUG WITHDRAWAL; DYSLIPIDEMIA; DYSPEPSIA; FEMALE; HEADACHE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; LIPID COMPOSITION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; METEORISM; MULTICENTER STUDY; MYALGIA; NAUSEA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SIDE EFFECT; STEATORRHEA; STOMACH PAIN; THERAPY EFFECT; TRIACYLGLYCEROL BLOOD LEVEL; VOMITING;

EID: 80055071716     PISSN: 1973798X     EISSN: 19737998     Source Type: Journal    
DOI: 10.1007/s12349-010-0043-6     Document Type: Article

References (17)

1. Hill AM, Fleming JA, Kris-Etherton PM (2009) The role of diet and nutritional supplements in preventing and treating cardiovascular disease. Curr Opin Cardiol 24:433-441
2. ATP III (2001) Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 285:2486-2496
3. Smith SC Jr, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC et al (2006) AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol 47:2130-2139 (Pubitemid 44275145)
4. Cicero AF, Rovati LC, Setnikar I (2007) Eulipidemic effects of berberine administered alone or in combination with other natural cholesterol lowering agents. A single-blind clinical investigation. Arzneimittelforschung 57:26-30 (Pubitemid 46212985)
5. Rumawas ME, Meigs JB, Dwyer JT, McKeown NM, Jacques PF (2009) Mediterranean-style dietary pattern, reduced risk of metabolic syndrome traits, and incidence in the Framingham offspring cohort. Am J Clin Nutr 90:1608-1614
6. Cicero AFG, Derosa G, Bove M, Borghi C, Gaddi AV (2009) Long-term effectiveness and safety of a nutraceutical based approach to reduce cholesterolemia in statin intolerant subjects with and without metabolic syndrome. Curr Topics Nutraceutical Res 7 (in press)
7. Setnikar I, Senin P, Rovati LC (2005) Antiatherosclerotic efficacy of policosanol, red yeast rice extract and astaxanthin in the rabbit Arzneimittel-Forschung (Drug Research) 55:312-317
8. Homocysteine Lowering Trialists' Collaboration (2005) Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. Am J Clin Nutr 82:806-812
9. Cohen J (1992) A power primer. Psychol Bull 112(1):155-159
10. Heber D, Yip I, Ashley JM, Elashoff DA, Elashoff RM, Liang V, Go W (1999) Cholesterol-lowering effects of a proprietary chinese red-yeast rice dietary supplement. Am J Clin Nutr 69:231-236 (Pubitemid 29065544)
11. Wang J, Su M, Lu Z et al (1995) Clinical trial of extract of Monascus purpureus (red yeast) in the treatment of hyperlipid-emia. Chin J Exp Ther Prep Chin Med 12:1-5
12. Brusq J-M, Ancellin N, Grondin P, Guillard R, Martin S, Saini-llan Y et al (2006) Inhibition of lipid synthesis through activation of AMP-kinase: an additional mechanism for the hypolipemic effect of berberine. J Lipid Res Feb 28 (epub)
13. Cicero AFG, Ertek S (2009) Metabolic and cardiovascular effects of berberine: from preclinical evidences to clinical trial results. Clin Lipidol 4:553-563
14. Caputi AP, Benvenuti C (2008) Armoweb Study Group improving the diet efficacy in hypercholesterolemic subjects with red yeast rice plus policosanol. L'Internista/Medicina Clinica.it 16:53-60
15. Kong W, Wei J, Abidi P, Lin M, Inaba S, Li C, Wang Y, Wang Z, Si S, Pan H, Wang S, Wu J, Wang Y, Li Z, Liu J, Jiang JD (2004) Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med 10:1344-1351 (Pubitemid 40022716)
16. Cicero AFG, Benvenuti C (2010) ARMoweb study Group Efficacy of a red yeast rice based nutraceutical in large subgroups of hypercholesterolemic subjects in every day clinical practice. Mediter J Nutr Metabol (in press)
17. Izzo R, de Simone G, Giudice R, Chinali M, Trimarco V, De Luca N, Trimarco B (2010) Effects of nutraceuticals on prevalence of metabolic syndrome and on calculated Framingham risk score in subjects with dyslipidemia. J Hypertension (in press)